Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Parissis

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Heart Failure|January 31, 2006
Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?John T Parissis, Dimitrios Farmakis, Dimitrios T Kremastinos
International Journal of Cardiology|June 25, 2003
New aspects for the role of physical training in the management of patients with chronic heart failureStamatis Adamopoulos, John T Parissis, Dimitrios Th Kremastinos
Heart Failure Reviews|July 6, 2019
Cardiogenic shock in cancerKalliopi Keramida, John T Parissis, Ovidiu Chioncel, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|June 25, 2005
Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heartIoannis A Paraskevaidis, John T Parissis, Dimitios Th Kremastinos
Current Molecular Medicine|March 13, 2003
Chemokines in cardiovascular remodeling: clinical and therapeutic implicationsGerasimos Filippatos, John T Parissis, Stamatis Adamopoulos, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 21, 2020
Differential effects of inotropes and inodilators on renal function in acute cardiac careEndre Zima, Dimitrios Farmakis, Piero Pollesello, et al.
Expert Opinion on Investigational Drugs|June 2, 2005
Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approachesJohn T Parissis, Katerina Fountoulaki, Ioannis Paraskevaidis, et al.
European Journal of Heart Failure|January 20, 2010
Rationale and design of the multicentre randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study)Johann Altenberger, John T Parissis, Hanno Ulmer, et al.
Frontiers in Psychology|November 3, 2025
Dance-based interventions in clinical populations: not all are the sameMichail Elpidoforou, Effie Polyzogopoulou, John T Parissis, et al.
International Journal of Cardiology|April 9, 2016
Non-obstructive left ventricular assist device outflow thrombus: What is the appropriate management?Vasiliki Bistola, John T Parissis, John Lekakis, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Heart Failure|January 31, 2006
Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?John T Parissis, Dimitrios Farmakis, Dimitrios T Kremastinos
International Journal of Cardiology|June 25, 2003
New aspects for the role of physical training in the management of patients with chronic heart failureStamatis Adamopoulos, John T Parissis, Dimitrios Th Kremastinos
Heart Failure Reviews|July 6, 2019
Cardiogenic shock in cancerKalliopi Keramida, John T Parissis, Ovidiu Chioncel, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|June 25, 2005
Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heartIoannis A Paraskevaidis, John T Parissis, Dimitios Th Kremastinos
Current Molecular Medicine|March 13, 2003
Chemokines in cardiovascular remodeling: clinical and therapeutic implicationsGerasimos Filippatos, John T Parissis, Stamatis Adamopoulos, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 21, 2020
Differential effects of inotropes and inodilators on renal function in acute cardiac careEndre Zima, Dimitrios Farmakis, Piero Pollesello, et al.
Expert Opinion on Investigational Drugs|June 2, 2005
Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approachesJohn T Parissis, Katerina Fountoulaki, Ioannis Paraskevaidis, et al.
European Journal of Heart Failure|January 20, 2010
Rationale and design of the multicentre randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study)Johann Altenberger, John T Parissis, Hanno Ulmer, et al.
Frontiers in Psychology|November 3, 2025
Dance-based interventions in clinical populations: not all are the sameMichail Elpidoforou, Effie Polyzogopoulou, John T Parissis, et al.
International Journal of Cardiology|April 9, 2016
Non-obstructive left ventricular assist device outflow thrombus: What is the appropriate management?Vasiliki Bistola, John T Parissis, John Lekakis, et al.
Pageof 11